Research Article

Metabolite Profiling, Pharmacokinetics, and In Vitro Glucuronidation of Icaritin in Rats by Ultra-Performance Liquid Chromatography Coupled with Mass Spectrometry

Table 1

UPLC-MS analysis of icaritin and its observed metabolites in biosamples.

NumberUV[M + H]+ErrorFormula(+) ESI-MS/MS(–) ESI-MS/MSSourcesCharacterization
minnmppm

M0#7.20272369.1336–0.5C21H20O6391.1152 369.1336 313.0714 215.0748367.1180 352.0941 309.0417 297.0399 281.0443 253.0485PUBFIIcaritin
M12.48270721.1978–0.3C33H36O18743.1882 721.1978 545.1666 369.1345 313.0717719.1825 543.1521 367.1194PUBIIcaritin-di-O-gluA
M22.62269563.17680.5C27H30O13563.1768 387.1442 369.1332 313.0716561.1608 385.1288UBIHydrated icaritin-O-gluA
M32.89345531.15111.5C26H26O12531.1511 355.1166 299.0576529.1348 353.1027 119.0504UBIDesmethylicaritin-O-gluA
M43.15341561.16171.6C27H28O13561.1617 385.1301 367.1186559.1456 383.1175 367.1135 175.0263UBIHydroxylated icaritin-O-gluA
M53.22341561.16130.9C27H28O13561.1613 385.1296559.1458 383.1172 175.0262UBIHydroxylated icaritin-O-gluA
M63.36345531.15030.0C26H26O12531.1503 355.1175 329.0741 314.0455529.1345 353.1025 119.0506UBIDesmethylicaritin-O-gluA
M73.41341561.1605–0.5C27H28O13561.1605 385.1295 313.0715559.1460 383.1171BIHydroxylated icaritin-O-gluA
M83.46270721.19820.3C33H36O18721.1982 545.1662 369.1340 313.0717719.1823 543.1519 367.1196UBIIcaritin-di-O-gluA
M93.52341561.16080C27H28O13561.1608 385.1283 559.1454 383.1170 175.0260BIHydroxylated icaritin-O-gluA
M103.58269563.1761–0.7C27H30O13563.1761 387.1452 369.1350 313.0735561.1605 385.1289UBIHydrated icaritin-O-gluA
M113.74341561.16151.2C27H28O13561.1615 385.1292 367.1186559.1462 383.1175BIHydroxylated icaritin-O-gluA
M124.29n.a.543.1501–0.4C27H26O12543.1501 367.1189 541.1343 365.1034 351.0765 175.0221 113.0253IDehydrogenated icaritin-O-gluA
M134.34271545.16630.7C27H28O12567.1486 545.1663 369.1335 313.0716543.1501 367.1188 352.0948 309.0408 297.0398 281.0498PUBFIIcaritin-O-gluA
M14#4.40270823.3024–0.1C39H50O19823.3024 369.1324 313.0721821.2863 659.2331 367.1168 351.0867IEpimedin C
M154.45273387.1440–1.0C21H22O7387.1440 369.1338 313.0722385.1288 IHydrated icaritin
M164.49270823.3021–0.5C39H50O19823.3021 369.1336 313.0725821.2860 659.2333 367.1165 351.0869IEpimedin C isomer
M17#4.53270531.18661.5C27H30O11531.1866 369.1350 313.0718529.1705 367.1182 352.0948 297.0395 253.0496FIIcariside I
M184.57271545.16610.4C27H28O12545.1661 369.1346 313.0723543.1505 367.1183 352.0945 297.0394PUBFIIcaritin-O-gluA
M194.59271647.23491.4C32H38O14669.2215 647.2349 515.1930 369.1346 313.0724645.2168 367.1162 351.0863 323.0945 295.0595IIcaritin-rha-xyl
M204.61270661.25031.1C33H40O14683.2326 661.2503 369.1339 313.0719659.2343 367.1165 351.0865 295.0602 217.0499FIIcaritin-rha-rha
M21#4.88269515.19271.9C27H30O10537.1757 515.1927 369.1340 313.0726513.1766 367.1157 352.0900 323.0910 295.0604 217.0498FIIcariside II
M224.93300543.1500–0.6C27H26O12565.1453 543.1500 367.1172541.1345 365.1033 175.0222 113.0254BIDehydrogenated icaritin-O-gluA
M234.97273387.14450.3C21H22O7387.1445 369.1343 313.0715385.1286UFIHydrated icaritin
M245.02300543.15050.4C27H26O12543.1505 367.1134 313.0720541.1346 365.1032 175.0223 113.0255BIDehydrogenated icaritin-O-gluA
M25#5.08270355.1180–0.6C20H18O6355.1180 299.0582353.1036 309.0409 297.0373 281.0481UFIDesmethylicaritin
M265.13271545.16640.9C27H28O12567.1540 545.1664 369.1343 313.0720 299.0585543.1504 367.1180 352.0942 297.0391BIIcaritin-O-gluA
M275.37268385.12880.3C21H20O7407.1136 385.1288 367.1186 313.0715383.1175 365.1035 175.0226UFIHydroxylated icaritin
M285.54268385.1285–0.5C21H20O7385.1285 367.1181 313.0719383.1170 365.1046UFIHydroxylated icaritin
M295.66n.a.385.12900.9C21H20O7385.1290 367.1176 313.0712383.1172 367.1043 175.0262UFIHydroxylated icaritin
M306.36272367.1180–0.5C21H18O6367.1180 352.0948 313.0721 297.0395 253.0496365.1047 351.0765 175.0223 113.0250FIDehydrogenated icaritin

M0, parent drug; M1~M34, metabolites; n.a., not available; P, plasma; U, urine; B, bile; F, feces; I, intestine. gluA, glucuronide conjugates; glc, glucose; rha, rhamnose; xyl, xylose.
# means that the metabolites are exactly identified with reference standards.